Roads Forward for European GMO Policy—Uncertainties in Wake of ECJ Judgment Have to be Mitigated by Regulatory Reform
Author:
Open Access
- 5 June 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 7, 132
Abstract
This article gives an overview of legal and procedural uncertainties regarding genome edited organisms and possible ways forward for European GMO policy. After a recent judgment by the European Court of Justice (ECJ judgment of 25 July 2018, C-528/16), organisms obtained by techniques of genome editing are GMOs and subject to the same obligations as transgenic organisms. Uncertainties emerge if genome edited organisms cannot be distinguished from organisms bred by conventional techniques, such as crossing or random mutagenesis. In this case, identical organisms can be subject to either GMO law or exempt from regulation because of the use of a technique that cannot be identified. Regulatory agencies might not be able to enforce GMO law for such cases in the long term. As other jurisdictions do not regulate such organisms as GMOs, accidental imports might occur and undermine European GMO regulation. In the near future, the EU Commission as well as European and national regulatory agencies will decide on how to apply the updated interpretation of the law. In order to mitigate current legal and procedural uncertainties, a first step forward lies in updating all guidance documents to specifically address genome editing specifically address genome editing, including a solution for providing a unique identifier. In part, the authorization procedure for GMO release can be tailored to different types of organisms by making use of existing flexibilities in GMO law. However, only an amendment to the regulations that govern the process of authorization for GMO release can substantially lower the burden for innovators. In a second step, any way forward has to aim at amending, supplementing or replacing the European GMO Directive (2001/18/EC). The policy options presented in this article presuppose political readiness for reform. This may not be realistic in the current political situation. However, if the problems of current GMO law are just ignored, European competitiveness and research in green biotechnology will suffer.Keywords
Funding Information
- Bundesministerium für Forschung, Technologie und Raumfahrt (01GP1613D)
This publication has 42 references indexed in Scilit:
- Principle and application of plant mutagenesis in crop improvement: a reviewBiotechnology & Biotechnological Equipment, 2015
- Specificity and Combinatorial Effects of Bacillus Thuringiensis Cry Toxins in the Context of GMO Environmental Risk AssessmentFrontiers in Environmental Science, 2015
- Safeguarding gene drive experiments in the laboratoryScience, 2015
- Limits of the current EU regulatory framework on GMOs: risk of not authorized GM event-traces in importsOCL, 2014
- Potential economic impacts of zero thresholds for unapproved GMOs: The EU caseFood Policy, 2014
- Site-directed nucleases: a paradigm shift in predictable, knowledge-based plant breedingTrends in Biotechnology, 2013
- Genome-wide genetic changes during modern breeding of maizeNature Genetics, 2012
- Deployment of new biotechnologies in plant breedingNature Biotechnology, 2012
- Ray florets color and shape mutants induced by 12C5+ ion beam irradiation in chrysanthemumScientia Horticulturae, 2010
- Genetically modified plants for non-food or non-feed purposes: Straightforward screening for their appearance in food and feedFood and Chemical Toxicology, 2010